These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6338128)

  • 1. Modulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids.
    Berman B; France DS; Martinelli GP; Hass A
    J Invest Dermatol; 1983 Mar; 80(3):168-71. PubMed ID: 6338128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of glucocorticosteroids on epidermal Langerhans cells.
    Furue M; Katz SI
    J Invest Dermatol; 1989 Mar; 92(3):342-7. PubMed ID: 2645371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells.
    Aberer W; Romani N; Elbe A; Stingl G
    J Immunol; 1986 Feb; 136(4):1210-6. PubMed ID: 2868057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucocorticosteroids on epidermal Langerhans cells.
    Belsito DV; Flotte TJ; Lim HW; Baer RL; Thorbecke GJ; Gigli I
    J Exp Med; 1982 Jan; 155(1):291-302. PubMed ID: 6459400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement receptors on guinea pig epidermal Langerhans cells.
    Berman B; Gigli I
    J Immunol; 1980 Feb; 124(2):685-90. PubMed ID: 7356709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glucocorticoids and gamma radiation on epidermal Langerhans cells.
    Belsito DV; Baer RL; Thorbecke GJ; Gigli I
    J Invest Dermatol; 1984 Feb; 82(2):136-8. PubMed ID: 6229585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of 2,4-dinitrophenyl groups on the epidermal Langerhans cells of guinea pigs following skin painting with 2,4-dinitrochlorobenzene.
    Oka D; Nakagawa S; Oota T; Ueki H
    Dermatologica; 1986; 172(1):12-7. PubMed ID: 3514298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
    Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
    J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-electron microscopic studies of surface receptors and antigens of human Langerhans cells.
    Rowden G
    Br J Dermatol; 1977 Dec; 97(6):593-608. PubMed ID: 341953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency classification of topical corticosteroids: modern perspectives.
    Ashworth J
    Acta Derm Venereol Suppl (Stockh); 1989; 151():20-5; discussion 47-52. PubMed ID: 2696307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glucocorticosteroids on epidermal cell-induced immune responses.
    Aberer W; Stingl L; Pogantsch S; Stingl G
    J Immunol; 1984 Aug; 133(2):792-7. PubMed ID: 6610710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
    Ashworth J; Booker J; Breathnach SM
    Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
    Katoh N; Hirano S; Kishimoto S; Yasuno H
    Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of epidermal Langerhans cells by immunoadsorption to Staphylococcus aureus cells.
    Schuler G; Auböck J; Linert J
    J Immunol; 1983 May; 130(5):2008-10. PubMed ID: 6339619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein.
    Rambukkana A; Pistoor FH; Bos JD; Kapsenberg ML; Das PK
    Lab Invest; 1996 Feb; 74(2):422-36. PubMed ID: 8780161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in epidermal Ia-positive cells in allergic contact sensitivity reactions in mice.
    Aiba S; Aizawa H; Obata M; Tagami H
    Br J Dermatol; 1984 Nov; 111(5):507-16. PubMed ID: 6388619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.